Immune System Diseases

905 trials 381 recruiting

Filter these 905 trials by phase, country and sponsor.

Open in Search →

JAK inhibitor dose TAPering strategy study in low disease activity rheumatoid arthritis patients. Recruiting

2023-509788-25-00 Rheumatoid arthritis 6 2025-06-16
Evaluation of 200 mg of Rituximab every 6 months as maintenance treatment of Rituximab-treated patients with rheumatoid arthritis: a non-inf… Recruiting

2024-519991-18-00 Rheumatoid Arthritis 6 2025-06-16
Complex immunomodulatory therapy for patients with immune thrombocytopenia (T-MEM) Recruiting

2023-505788-35-00 Immune thrombocytopenia 4 2025-06-11
Plasma cell targeting in ME/CFS Recruiting

2024-520094-13-00 Myalgic Encephalomyelitis/Chronic Fatigue Syndrome 4 2025-06-11
A Clinical Trial to Test the Safety, Tolerability, and How the Body Processes CPV-104 in Healthy People and Patients with C3-Glomerulopathy Recruiting

2024-517992-19-00 C3 glomerulopathy (C3G) 1 2025-06-11
REscue of Nephrons with ALe.F02 (RENAL F02) Recruiting

2022-502184-38-00 Rapidly progressive glomerulonephritis 4 2025-06-06
An open-label extension study to assess the efficacy and safety of ianalumab with or without study treatment withdrawal in adult participan… Recruiting

2024-515280-60-00 Lupus nephritis 5 2025-05-29
Evaluation of the efficacy and safety of dual biologic and/or small molecule therapy in patients with induction-resistant ulcerative colitis… Recruiting

2023-506628-98-00 Ulcerative colitis 4 2025-05-27
Blocage de l'interféron-ɣ par le ruxolitinib pour le traitement de la myosite à inclusion : un essai de phase IIb Recruiting

2023-507666-32-00 Inclusion body Myositis 4 2025-05-27
A study to find how well Dazodalibep works and how safe it is in participants with Sjôgren`s Syndrome Recruiting

2024-517513-32-00 Sjögren’s Syndrome 5 2025-05-16
Interventional, multicenter, open-label, randomized, non-comparative trial evaluating the safety, in terms of HBV virological control, of 2 … Recruiting

2023-508634-34-00 co-infected with the HIV-1 and HBV viruses 4 2025-05-14
A study to assess the effectiveness and safety of pacritinib in patients with VEXAS syndrome (PAXIS) Recruiting

2024-516347-41-00 VEXAS Syndrome 4 2025-04-29
T-Guard in dcSSc Recruiting

2024-517283-28-00 diffuse cutaneous systemic sclerosis 9 2025-04-29
A Study of the Efficacy and Safety of JNJ-77242113 in Biologic-experienced Participants with Active Psoriatic Arthritis Recruiting

2024-517284-23-00 Active Psoriatic Arthritis 5 2025-04-23
Randomized, double-blind, placebo-controlled, two-part study assessing the safety, tolerability and pharmacokinetics of BP1.7881 administere… Recruiting

2024-512722-28-00 Eosinophilic esophagitis 3 2025-04-22
Evaluation of the efficacy and safety of dual biological therapy in patients with refractory Crohn's disease resistant to induction (FLAMING… Recruiting

2023-506626-37-00 Crohn's disease 4 2025-04-18
A multicenter, single-arm, open-label study to evaluate efficacy and safety of switching from anti-C5 antibody treatment to iptacopan treatm… Recruiting

2023-504550-35-00 Atypical Hemolytic Uremic Syndrome (aHUS) 5 2025-04-03
Botox Treatment for Patients with Hidradenitis Suppurativa: A Within-Person, Randomized, Double-blind, Controlled Study Recruiting

2024-519946-54-00 Hidradenitis Suppurativa 6 2025-04-01
A clinical proof-of-concept study to reduce smoldering inflammation in progressive MS Recruiting

2024-517336-21-00 Progressive multiple sclerosis 4 2025-03-31
A Phase 1/2, Open-Label Study to Evaluate the Safety and Efficacy of Autologous CD19-specific Chimeric Antigen Receptor T cells (CABA-201) i… Recruiting

2023-507613-10-01 Active Systemic Lupus Erythematosus;Systemic lupus eryt 7 2025-03-31
An open-label extension study with dazukibart for participants with idiopathic inflammatory myopathies (including DM or PM) who have complet… Recruiting

2024-514648-10-00 Idiopathic Inflammatory Myopathy (including dermatomyos 5 2025-03-14
Direct comparison between NSAIDs and biosimilar TNFa blockers in patients with axial spondyloarthritis Recruiting

2024-513213-13-00 Axial Spondyloarthritis 6 2025-03-13
A randomized trial comparing efficacy and safety of etanercept and methotrexate in giant cell arteritis (EFFECTA) Recruiting

2023-506623-29-01 Giant cell arteritis 4 2025-03-12
First-line immunotherapy-based standard of care and local ablative treatments for oligometastatic non-small cell lung cancer patients: a ran… Recruiting

2023-503326-39-00 Synchronous oligometastatic non-small cell lung cancer 5 2025-03-06